XML 1081 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6

Accrued and Other Current Liabilities

9 Months Ended

12 Months Ended

Sep. 30, 2012

Dec. 31, 2011

Accrued and Other Current Liabilities

Accrued and Other Current Liabilities

6. ACCRUED LIABILITIES AND OTHER CURRENT LIABILITIES

Accrued and other current liabilities consisted of the following:

		December 31, 2011		September 30, 2012
		($000s)
Accrued research and development		3,471		3,335
Other current liabilities		712		792
		4,183		4,127

During the nine months ended September 30, 2012, the Company recorded out of period reversals of pre-clinical expense accruals of $0.4 million as a decrease to accrued liabilities and other current liabilities on the consolidated balance sheets and as a decrease to research and development expenses on the consolidated statements of operations.

9 Accrued and Other Current Liabilities

Accrued and other current liabilities consisted of the following:

		December 31,
		2010		2011
		$000		$000
Accrued research and development		2,793		3,471
Other current liabilities		961		712
		3,754		4,183

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

No definition available.

+ Details

Name:	us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration